生物活性 | |||
---|---|---|---|
描述 | PHA-665752 is an ATP-competitive and selective c-Met inhibitor with Ki value of 4nM, exhibiting >50-fold selectivity for c-Met compared with a panel of diverse tyrosine and serine-threonine kinases. PHA-665752 dose-dependently inhibited HGF-induced c-Met phosphorylation in A549 cells at concentration ranging in 0.025-0.2μM and suppressed HGF-induced migration in NCI-H441 cells at concentration of 0.1μM. Treatment with 0.1μM PHA-665752 for 3 hours could potently inhibit constitutive signaling through ERK, Akt, FAK, PLC-γ and STAT pathways in GTL-16 cells. Intravenous injection with PHA-665752 could dose-dependently reduce the tumor growth of athymic mice bearing S114 tumors at dose of 7.5, 15 and 30mg/kg, daily for 10 days, and significantly inhibit the tumor growth in the GTL-16 gastric tumor xenograft model, at dose of 25mg/kg, daily for 9 days. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
697 | Growth Inhibition Assay | IC50=28.7633 μM | SANGER | ||
A498 | Growth Inhibition Assay | IC50=8.28446 μM | SANGER | ||
ACN | Growth Inhibition Assay | IC50=22.2497 μM | SANGER |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02002416 | - | Unknown | December 2014 | China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.56mL 0.31mL 0.16mL |
7.79mL 1.56mL 0.78mL |
15.59mL 3.12mL 1.56mL |
参考文献 |
---|